CMC Project Lead (Next Generation Biologics and ADCs), London
Lead the CMC strategy for next-generation biologics and Antibody-Drug Conjugates (ADCs), overseeing end-to-end technical development from cell line optimisation to precision conjugation and manufacturing scale-up. Serve as the technical authority, managing CMC aspects of regulatory filings and guiding global contract partners to ensure robust, scalable pathways for AI-designed therapeutics.